BIRC6 and hepatocellular carcinoma: It specifically analyzed the regulatory dynamics of the circ-BIRC6/miR-877-5p/YWHAZ axis in HCC cells, providing valuable insights and outlining a potential therapeutic pathway for treating HCC with paclitaxel [29].